Prudential Financial
HOWL icon

Prudential Financial’s Werewolf Therapeutics HOWL Stock Holding History

Prudential Financial’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,400
Closed -$59.4K – 2701
2023
Q4 		$59.4K Hold
15,400
– – ﹤0.01% 2537
2023
Q3 		$33K Sell
15,400
-4,400
-22% -$12.1K ﹤0.01% 2540
2023
Q2 		$60.4K Hold
19,800
– – ﹤0.01% 2515
2023
Q1 		$51.5K Sell
19,800
-1,200
-6% -$3.58K ﹤0.01% 2496
2022
Q4 		$43K Buy
+21,000
New +$54.9K ﹤0.01% 2508

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Prudential Financial's HOWL Position: Q1 2024 in Review

Prudential Financial sold out of Werewolf Therapeutics (HOWL) in Q1 2024, closing a stake of 15,400 shares — an estimated $59.4K sold.

Prudential Financial first reported a position in HOWL in Q4 2022 and held it in 5 quarters. The position peaked at $60.4K in Q2 2023. 61 funds tracked by Wall St. Rank hold HOWL as of Q1 2024.

  • Prudential Financial reported no remaining Werewolf Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Prudential Financial sold 15,400 Werewolf Therapeutics shares in Q1 2024, an estimated $59.4K.
  • Prudential Financial first reported a position in Werewolf Therapeutics in Q4 2022 and held it in 5 quarters.
  • Prudential Financial's Werewolf Therapeutics position peaked at $60.4K in Q2 2023.
  • 61 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2024.

Based on Prudential Financial's 13F filing for Q1 2024, filed 14 May 2024.